BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

26 related articles for article (PubMed ID: 2282099)

  • 1. Thiazolidinedione-independent activation of peroxisome proliferator-activated receptor γ is a potential target for diabetic macrovascular complications.
    Matsumura T; Taketa K; Shimoda S; Araki E
    J Diabetes Investig; 2012 Feb; 3(1):11-23. PubMed ID: 24843540
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nifedipine inhibits accumulation of low density lipoprotein and cholesterol in the aorta of normocholesterolaemic rabbits.
    Görög P; Born GV
    Drugs; 1994; 48 Suppl 1():8-10. PubMed ID: 7533705
    [No Abstract]   [Full Text] [Related]  

  • 3. Nifedipine suppressed atherosclerosis in cholesterol-fed rabbits but not in Watanabe heritable hyperlipidemic rabbits.
    Watanabe N; Ishikawa Y; Okamoto R; Watanabe Y; Fukuzaki H
    Artery; 1987; 14(5):283-94. PubMed ID: 3662844
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cholesterol-fed heterozygous Watanabe heritable hyperlipidemic rabbits: a new model for atherosclerosis.
    Atkinson JB; Hoover RL; Berry KK; Swift LL
    Atherosclerosis; 1989 Aug; 78(2-3):123-36. PubMed ID: 2783197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Failure of nifedipine to reduce atherogenesis in cholesterol-fed rabbits.
    Overturf ML; Smith SA
    Artery; 1986; 13(5):267-82. PubMed ID: 3527114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. No effect of nifedipine on atherogenesis in cholesterol-fed rabbits.
    Stender S; Stender I; Nordestgaard B; Kjeldsen K
    Arteriosclerosis; 1984; 4(4):389-94. PubMed ID: 6466196
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does nifedipine suppress atherogenesis in WHHL rabbits?
    Van Niekerk JL; Hendriks T; De Boer HH; Van 't Laar A
    Atherosclerosis; 1984 Oct; 53(1):91-8. PubMed ID: 6497947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nifedipine reduces atherogenesis in cholesterol-fed heterozygous WHHL rabbits.
    Atkinson JB; Swift LL
    Atherosclerosis; 1990 Oct; 84(2-3):195-201. PubMed ID: 2282099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atherosclerosis regression in animal models: current concepts of cellular and biochemical mechanisms.
    St Clair RW
    Prog Cardiovasc Dis; 1983; 26(2):109-32. PubMed ID: 6414047
    [No Abstract]   [Full Text] [Related]  

  • 10. Watanabe rabbits with heritable hypercholesterolaemia: a model of atherosclerosis.
    Aliev G; Burnstock G
    Histol Histopathol; 1998 Jul; 13(3):797-817. PubMed ID: 9690137
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of calcium antagonists in progression of arteriosclerosis. Evidence from animal experiments and clinical experience. Part I. Preventive effects of calcium antagonists in animal experiments.
    Frey M; Just H
    Basic Res Cardiol; 1994; 89 Suppl 1():161-76. PubMed ID: 7945170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of nifedipine on experimental arteriosclerosis.
    Knorr AM; Kazda S
    Cardiovasc Drugs Ther; 1990 Aug; 4 Suppl 5():1027-31. PubMed ID: 2076389
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.